![]() |
市場調査レポート
商品コード
1451538
神経デバイス市場レポート:製品、エンドユーザー、地域別、2024-2032Neurology Devices Market Report by Product, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
神経デバイス市場レポート:製品、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界の神経デバイス市場規模は2023年に134億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに251億米ドルに達し、2024年から2032年の間に7.1%の成長率(CAGR)を示すと予測しています。
神経学は、神経系の疾患や障害を扱う医学の一分野です。神経学で広く使われている装置には数多くの種類があります。例えば、仙骨神経刺激装置は、腰部にある標的の仙骨神経に電気インパルスを送ることで機能します。一方、脳脊髄液管理装置は、脳脊髄液の流れを維持し、脳から余分な液を排出します。一方、脳深部刺激装置は、脳の特定の標的部位に電気インパルスを送る医療機器を埋め込むことによって、処置の実行を助ける。これらの装置は複雑な疾患の治療に役立っています。その結果、強迫性障害、パーキンソン病、ジストニア、慢性疼痛、本態性振戦、大うつ病など、数多くの神経疾患の治療に広く応用されています。
市場は主にヘルスケア分野の大幅な成長によって牽引されています。これに加えて、世界中で神経疾患の有病率が高まっていることも、製品需要に大きく寄与しています。高齢者人口の増加や、高齢者における脳卒中などの神経血管疾患の発生率の上昇が、神経学的装置の採用をさらに後押しし、市場の成長を増大させています。さらに、神経デバイスにおける継続的な技術進歩や、低侵襲(MI)手術に対する広範な需要も、世界中で重要な成長促進要因として作用しています。市場成長に弾みをつけるその他の要因としては、ヘルスケア支出の拡大、世界の医療機器メーカーによる巨額の投資、神経治療分野における広範な研究開発(R&D)などが挙げられます。
The global neurology devices market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.
Neurology is a stream of medical science that deals with diseases and disorders of the nervous system. There are numerous types of devices that are widely used in neurology. For instance, sacral nerve stimulation devices function by sending electrical impulses to the targeted sacral nerves located in the lower back. On the other hand, cerebrospinal fluid management devices maintain the cerebrospinal fluid flow and drain excess fluid from the brain. In line with this, interventional devices use radiology and catheters to diagnose the medical conditions present in the central nervous system, whereas deep brain stimulation devices aid in performing procedures by implanting a medical device that sends electrical impulses to specific target areas in the brain. These devices are instrumental in treating complex disorders. As a result, they find widespread applications in the treatment of numerous neurological disorders, such as obsessive-compulsive disorder, Parkinson's disease, dystonia, chronic pain, essential tremor, and major depression.
The market is primarily driven by considerable growth in the healthcare sector. In addition to this, the growing prevalence of neurological disorders across the globe is significantly contributing to the product demand. The increasing geriatric population and the rising incidences of neurovascular conditions, such as stroke, among the elderly are further propelling the adoption of neurology devices, thereby augmenting the growth of the market. Moreover, continual technological advancements in neurology devices and the widespread demand for minimally invasive (MI) surgeries are also acting as significant growth-inducing factors across the globe. Some of the other factors providing an impetus to the market growth include the expanding healthcare expenditure, huge investments made by global medical device manufacturers and extensive research and development (R&D) in the field of neurotherapy.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurology devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end user.
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Management Devices
Others
Hospitals
Ambulatory Surgery Centers
Neurology Clinics
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun, Boston Scientific Corporation, Integra LifeSciences, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Penumbra Inc. and Stryker Corporation.